JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 28 filers reported holding JASPER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.07 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,586,797 | -48.9% | 11,219,036 | 0.0% | 6.12% | -55.6% |
| Q2 2023 | $14,848,445 | -24.3% | 11,219,036 | 0.0% | 13.79% | -17.6% |
| Q1 2023 | $19,617,289 | +1331.3% | 11,219,036 | +248.5% | 16.72% | +1280.8% |
| Q4 2022 | $1,370,606 | -38.8% | 3,219,036 | 0.0% | 1.21% | -45.5% |
| Q3 2022 | $2,240,000 | -59.1% | 3,219,036 | 0.0% | 2.22% | -60.0% |
| Q2 2022 | $5,478,000 | -46.2% | 3,219,036 | 0.0% | 5.56% | -41.2% |
| Q1 2022 | $10,180,000 | -55.6% | 3,219,036 | 0.0% | 9.45% | -46.9% |
| Q4 2021 | $22,945,000 | – | 3,219,036 | – | 17.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 5,852,982 | $20,778,000 | 19.52% |
| Velan Capital Investment Management LP | 3,219,036 | $10,180,000 | 9.45% |
| Abingworth LLP | 5,628,558 | $19,531,000 | 5.54% |
| SECTORAL ASSET MANAGEMENT INC | 675,000 | $2,396,000 | 0.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 540,000 | $1,917,000 | 0.20% |
| Vahanian & Associates Financial Planning Inc. | 10,000 | $36,000 | 0.08% |
| Forefront Analytics, LLC | 32,550 | $118,000 | 0.04% |
| Citadel Advisors | 2,994,580 | $10,631,000 | 0.00% |
| FEDERATED HERMES, INC. | 251,697 | $894,000 | 0.00% |
| Ionic Capital Management LLC | 100 | $0 | 0.00% |